Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Real-World Evidence User-Fee Funding Praised At FDA Meeting

Executive Summary

Patient advocacy groups unanimously thanked FDA and industry for including patient engagement and real-world evidence elements in the new user-fee deal during a Nov. 2 meeting. RWE was initially a point of disagreement during negotiations between FDA and industry, but industry cautiously supported pilot funding.

Advertisement

Related Content

Software Fast Track? US FDA Asks Developers To Envision 'Precheck' Program
Despite Cures Boost, Lingering Appropriations Means FDA Device Funding Still An Unknown For 2017
Device Standards Provision In Cures Bill Could Speed Up 510(k) Clearances
Medical Innovation Bills On Fast Track In Congress, But Some Barriers Remain
Pilot Of New US Evaluation System Will Include At Least Two Devices
MDIC Snags $3m For FDA Real-World Evidence Coordinating Center
Industry Urges Caution In Response To Growing Push For 'Real-World' Device Evaluation System

Topics

Advertisement
UsernamePublicRestriction

Register

MT104044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel